CSIMarket
Theravance Biopharma inc   (TBPH)
Other Ticker:  
 
 

Theravance Biopharma Inc 's Yearly Net Income Growth 5 Years

 

Select the Comparisons : Select the Ratio:



TBPH Annual Net Income Growth

2022
2021
2020
2019
2018
Y / Y Annual Net Income Change - - - - -
Annual Net Income (in millions $) $872.13 $-199.43 $-278.02 $-236.46 $-215.52


Annual Net Income Growth Comment
In the fiscal year ended 2022, company achieved Annual Net Income of $872.13 millions compare to net loss of $-199.43 millions realized a year before.

Theravance Biopharma Inc Annual Income Statement




You need to upgrade your Flash Player



Companies with similar 2022 Annual Net Income within Healthcare SectorY/Y Net Income Growth %2022 Annual Net Income
Novartis Ag -71.04 %$ 6,955.000  millions
Sinovac Biotech Ltd -99.39 %$ 88.131  millions
Moderna Inc -31.47 %$ 8,362.000  millions
Regeneron Pharmaceuticals Inc -46.28 %$ 4,338.400  millions
Hca Healthcare Inc -11.49 %$ 6,834.000  millions
Abbott Laboratories -1.95 %$ 6,933.000  millions
Bristol myers Squibb Company -9.54 %$ 6,345.000  millions
Gilead Sciences Inc -26.37 %$ 4,566.000  millions
3m Company -2.33 %$ 5,791.000  millions
Amgen Inc   11.18 %$ 6,552.000  millions
Eli Lilly And Company  11.88 %$ 6,244.800  millions
Bio rad Laboratories Inc